Teva Pharmaceutical Industries Ltd. announced that the FDA has on 28 March 2013, approved Quartette, (levonorgestrel/ethinyl estradiol and ethinyl estradiol)...
New pivotal Phase III data showing 45% of children with active systemic juvenile idiopathic arthritis (SJIA) were able to substantially...
NICE has issued new draft guidance recommending Firmagon (degarelix), from Ferring Pharmaceuticals, as an option for treating Prostate Cancer in...